AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BriaCell Therapeutics Corp. Warrant

$0.13 -$0.11 (-46.94%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$0.14
Day Range
$0.12$0.13
Year Range
$0.13$0.13
Market Cap
244.89K
AVG Volume
131.84K
Trailing/Forward PE
-0.29/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Net Income (USD)
-15M-10M-5M05M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q3-7.16M
26 Q2-7.22M
26 Q1-8.2M
25 Q4-8.07M
25 Q3-6.13M
25 Q2-6.29M
25 Q1-5.8M
24 Q4-1.2M
24 Q31.7M
24 Q2-11.37M
Operating Income (USD)
-10M-7.5M-5M-2.5M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q3-7.62M
26 Q2-7.53M
26 Q1-8.32M
25 Q4-8.53M
25 Q3-6.33M
25 Q2-7.17M
25 Q1-5.15M
24 Q4-5.69M
24 Q3-9.16M
24 Q2-9.89M
EBITDA (USD)
-10M-7.5M-5M-2.5M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q3-7.17M
26 Q2-7.5M
26 Q1-8.3M
25 Q4-8.5M
25 Q3-6.16M
25 Q2-7.14M
25 Q1-5.13M
24 Q4-5.62M
24 Q3-9.16M
24 Q2-9.89M
Cash Flows (USD)
-10M-7.5M-5M-2.5M024 Q124 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q3-7.14M
26 Q2-7.97M
26 Q1-7.7M
25 Q4-8.13M
25 Q3-7.16M
25 Q2-5.92M
25 Q1-6.96M
24 Q4-4.51M
24 Q3-4.99M
24 Q1-7.5M
EPS (USD)
-150-100-5005024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ EPS (USD) by quarter
PeriodEPS (USD)
26 Q3-0.99
26 Q2-2.58
26 Q1-4.35
25 Q4-4.28
25 Q3-16.4
25 Q2-23.31
25 Q1-32.67
24 Q4-9.97
24 Q315.98
24 Q2-106.69
Expenses (USD)
02.5M5M7.5M10MR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Expenses (USD) by quarter
PeriodExpenses (USD)
24 Q10
26 Q37.75M
26 Q27.53M
26 Q18.32M
25 Q48.5M
25 Q36.33M
25 Q27.17M
25 Q15.15M
24 Q46.07M
24 Q39.16M
24 Q29.89M
Cash & Debt (USD)
010M20M30MCashShort Term Debt24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q322.8M
26 Q229.65M
26 Q110.18M
25 Q417.93M
25 Q312.46M
25 Q24.92M
25 Q15.79M
24 Q4858.21K
24 Q3940.29K
24 Q26.21M
Debt ratios
00.250.50.75124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Debt ratios by quarter
PeriodDebt ratios
26 Q30.72
26 Q20.97
26 Q10.34
25 Q40.67
25 Q30.52
25 Q20.18
25 Q10.19
24 Q40.03
24 Q30.03
24 Q20.2
Return on Capital
-200%-100%0%100%200%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Return on Capital by quarter
PeriodReturn on Capital
26 Q3-30.61%
26 Q2-23.9%
26 Q1-87.67%
25 Q4-46.4%
25 Q3-51.31%
25 Q2-194.97%
25 Q1-156.27%
24 Q444.83%
24 Q3-27.19%
24 Q2137.48%
Shares Outstanding
02M4M6M8M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Shares Outstanding by quarter
PeriodShares Outstanding
26 Q37.25M
26 Q22.8M
26 Q11.88M
25 Q41.88M
25 Q3373.55K
25 Q2269.96K
25 Q1177.61K
24 Q4120.18K
24 Q3106.54K
24 Q2106.54K
Book Value Per Share (USD)
-100-5005024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q33.23
26 Q210.78
26 Q14.96
25 Q49.23
25 Q331.97
25 Q211.95
25 Q120.91
24 Q4-22.24
24 Q3-58.79
24 Q2-77.61
Total Assets (USD)
010M20M30M40M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q327.07M
26 Q233.59M
26 Q113.08M
25 Q421.72M
25 Q317M
25 Q29.36M
25 Q110.41M
24 Q45.85M
24 Q36.23M
24 Q212.16M
Employee Count
010203020212022202320242025
BCTXZ Employee Count by quarter
PeriodEmployee Count
202522
202417
202311
202211
20212
Free Cash Flow Yield
-50000%-40000%-30000%-20000%-10000%0%med -8068.57%Jun 25Aug 25Nov 25Jan 26Apr 26Jun 26Sep 26
BCTXZ Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-2962.09%
Sep 26-2307.23%
Aug 26-3161.75%
Aug 26-4065.11%
Aug 26-3880.33%
Aug 26-4785.17%
Jul 26-4747.91%
Jul 26-4281.21%
Jul 26-4272.64%
Jul 26-4272.64%
Jul 26-4742.63%
Jun 26-13829.82%
Jun 26-13864.53%
Jun 26-13829.82%
Jun 26-13899.41%
May 26-13812.53%
May 26-13812.53%
May 26-13829.82%
May 26-12291.47%
May 26-11755.35%
Apr 26-10523.84%
Apr 26-7748.97%
Apr 26-7366.68%
Apr 26-10045.48%
Mar 26-11808.05%
Mar 26-13371.48%
Mar 26-9314.6%
Mar 26-10586.52%
Feb 26-9158.99%
Feb 26-9164.45%
Feb 26-10233.64%
Feb 26-8771.69%
Jan 26-8068.57%
Jan 26-9303.31%
Jan 26-7675.23%
Jan 26-5685.36%
Jan 26-6265.49%
Dec 25-4984.17%
Dec 25-3833.97%
Dec 25-4146.56%
Dec 25-3867.69%
Nov 25-3996.93%
Nov 25-5191.84%
Nov 25-3924.54%
Nov 25-4984.17%
Oct 25-3733.46%
Oct 25-3251.25%
Oct 25-3603.88%
Oct 25-3338.36%
Oct 25-3324.26%
Sep 25-23468.41%
Sep 25-30923.09%
Sep 25-31668.22%
Sep 25-34585.03%
Aug 25-41044.07%
Aug 25-29868.89%
Aug 25-26295.14%
Aug 25-24446.26%
Aug 25-23476.8%
Jul 25-18801.59%
Jul 25-18780.1%
Jul 25-13139.68%
Jul 25-6199.2%
Jun 25-7744.36%
Jun 25-8123.99%
Jun 25-8382.02%
Jun 25-7891.88%
May 25-7533.15%
May 25-7744.36%
May 25-8204.43%
May 25-8815.39%
May 25-7022.43%
Apr 25-6325.55%
Price to Book
00.050.10.15med 0.03Jun 25Aug 25Nov 25Jan 26Apr 26Jun 26Sep 26
BCTXZ Price to Book by quarter
PeriodPrice to Book
Sep 260.04
Sep 260.06
Aug 260.04
Aug 260.03
Aug 260.03
Aug 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jun 260.01
Jun 260.01
Jun 260.01
Jun 260.01
May 260.01
May 260.01
May 260.01
May 260.01
May 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Mar 260.03
Mar 260.02
Mar 260.03
Mar 260.03
Feb 260.03
Feb 260.03
Feb 260.03
Feb 260.04
Jan 260.04
Jan 260.03
Jan 260.04
Jan 260.05
Jan 260.05
Dec 250.03
Dec 250.04
Dec 250.04
Dec 250.04
Nov 250.04
Nov 250.03
Nov 250.04
Nov 250.03
Oct 250.04
Oct 250.05
Oct 250.04
Oct 250.05
Oct 250.05
Sep 250.01
Sep 250.01
Sep 250.01
Sep 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Jul 250.01
Jul 250.01
Jul 250.02
Jul 250.03
Jun 250.09
Jun 250.09
Jun 250.08
Jun 250.09
May 250.09
May 250.09
May 250.08
May 250.08
May 250.1
Apr 250.11
BriaCell Therapeutics Corp. Warrant
BCTXZ
Stockpicker

Video analysis: BCTXZ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.